McKesson Specialty Health Launches Optimization Toolkit for Oncology In-Office Dispensing Program

THE WOODLANDS, Texas–(BUSINESS WIRE)–McKesson
Specialty Health announced today the enhancement of its widely
acclaimed In-Office Dispensing program for oncology practices by
launching an Optimization Toolkit to drive improved financial
performance and patient care excellence. The McKesson In-Office
Dispensing program for oral oncolytics was first launched in 2010 to
help oncology practices deliver local, high-quality oral chemotherapy to
their patients and increase their revenue. The new Optimization Toolkit
adds unique components to the McKesson In-Office Dispensing program,
including data analytics and dedicated oncology pharmacy expertise, as
well as high touch operational support across marketing, workflow
training and legal guidance. These Toolkit products and services help
practices take their in-office dispensing business to the next level,
maximizing revenue and ensuring therapy adherence and continuity of care
in today’s challenging healthcare landscape.
“More than half of the current phase III oncology pipeline is comprised
of oral therapies, and the future will bring even more of these
innovative treatments to the forefront,” said Randy Hyun, senior vice
president and general manager of Provider Solutions for McKesson
Specialty Health. “McKesson’s In-Office Dispensing program, along with
the Optimization Toolkit, can help practices take advantage of this
dramatic increase in oral oncolytics and identify revenue growth
opportunities while supporting the delivery of safe, efficient
high-quality care for patients.”
The Optimization Toolkit is the first of its kind in the marketplace,
providing several invaluable components to drive financial performance
and exceptional care, including:

• Data Analytics
  • Diagnostic data analytics that deliver useful, actionable
    intelligence by analyzing key metrics to uncover opportunities for
    business optimization
  • Benchmarking, goal setting and post optimization engagement
    analytics to measure success

• Pharmacy Optimization Team
  • Strategic engagement opportunities with pharmacy experts designed
    to help practices diagnose opportunities and affect positive change
• Operational Support
  • Suite of customizable tools and templates and expert guidance for
    practices looking to market their services to patients and
    prescribers
  • Advanced workflow and pharmacy training courses to enable
    practices to increase efficiency
  • Exclusive legal platform with guidance on state regulations for
    physician dispensing and retail pharmacy models

“Supporting practices in optimizing and growing their dispensing
programs is an important investment area for McKesson Specialty Health,”
said Brandon Tom, senior director of Oral Oncolytic Services for
McKesson Specialty Health. “We have helped more than 1,000 physicians
implement dispensing capabilities over the last four years, so it’s
important that we also focus on ensuring that they continue to evolve
their programs to thrive in a rapidly changing environment. Establishing
a network of practices as a best-in-class site of care for oral
oncolytics is not only critical in providing the best patient care
possible, but also in creating collaborative relationships with the
payer and manufacturer community.”
In-office dispensing of oral medications delivers key benefits to both
cancer patients and practices by empowering seamless, uninterrupted
quality care, enhancing practice revenue while providing a better
patient experience, and supporting optimal outcomes. Comprehensive,
in-house medication management enables improved medication compliance
and continuity of care through better control of patient IV and oral
therapy. Additionally, it is more convenient for patients, as it reduces
the need to send them to an outside pharmacy or hospital for prescribed
medications.
“In the face of rising drug costs and decreasing reimbursements,
community oncology practices need to consider innovative solutions to
ensure practice growth and survival. Our in-office dispensing solution
can help practices to not only expand their services and grow revenue,
but also prepare for the many changes that will impact oncology – and
most importantly, patient care – in the future,” Hyun concluded.
About McKesson Specialty Health
McKesson Specialty Health, a division of McKesson Corporation, empowers
the community patient care delivery system by helping community
practices advance the science, technology and quality of care. Through
innovative clinical, research, business and operational solutions,
facilitated by integrated technology systems, we focus on improving the
financial health of our customers so they may provide the best care to
their patients. For more information, visit www.mckessonspecialtyhealth.com.